Insider Transactions in Q2 2025 at Travere Therapeutics, Inc. (TVTX)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 15
2025
|
Roy D. Baynes |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+14.77%
|
-
|
|
May 15
2025
|
Suzanne Louise Bruhn |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+18.44%
|
-
|
|
May 15
2025
|
Timothy Coughlin |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+10.48%
|
-
|
|
May 15
2025
|
Gary A Lyons |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+10.16%
|
-
|
|
May 15
2025
|
Jeffrey A Meckler |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+6.91%
|
-
|
|
May 15
2025
|
John A Orwin |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+15.52%
|
-
|
|
May 15
2025
|
Sandra Poole |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+17.81%
|
-
|
|
May 15
2025
|
Ron Squarer |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+15.52%
|
-
|
|
May 15
2025
|
Brinkley Ruth Williams |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+20.16%
|
-
|
|
May 05
2025
|
Elizabeth E Reed Chief Legal Officer and GC |
SELL
Open market or private sale
|
Direct |
4,920
-5.21%
|
$103,320
$21.05 P/Share
|
|
May 05
2025
|
William E. Rote Chief Research Officer |
SELL
Open market or private sale
|
Direct |
3,198
-3.09%
|
$67,158
$21.05 P/Share
|
|
May 05
2025
|
Peter Heerma CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,771
-1.36%
|
$37,191
$21.05 P/Share
|
|
May 05
2025
|
Eric M Dube CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
18,924
-4.32%
|
$397,404
$21.05 P/Share
|
|
May 05
2025
|
Christopher R. Cline CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,784
-1.88%
|
$37,464
$21.05 P/Share
|
|
May 02
2025
|
Elizabeth E Reed Chief Legal Officer and GC |
BUY
Exercise of conversion of derivative security
|
Direct |
4,920
+4.95%
|
-
|
|
May 02
2025
|
William E. Rote Chief Research Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,920
+4.54%
|
-
|
|
May 02
2025
|
Peter Heerma CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,920
+3.65%
|
-
|
|
May 02
2025
|
Eric M Dube CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
18,924
+4.14%
|
-
|
|
May 02
2025
|
Christopher R. Cline CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,920
+4.93%
|
-
|
|
Apr 11
2025
|
Christopher R. Cline CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
48
-0.05%
|
$624
$13.14 P/Share
|